Company intelligence / Profile preview

Aenorasis

Ownership: Private
Development stage: Other

Overview

Aenorasis markets and distributes innovative pharmaceutical products—including originators, generics, biosimilars—and high-standard medical devices in Greece. The company holds a leading position in drug administration pumps and diagnostic products. It does not appear to conduct its own clinical trials but acts as a representative/distributor for global pharma firms. No direct clinical results are published by the company.

Therapeutic areas: Women's HealthImmunologyOncologyOther
Modalities: Small moleculeBiologicBiosimilarGeneric drug (Small molecule)Diagnostic device (Device)Drug delivery device (Device)
Industry: Non-Academic Healthcare

Partnerships

Represents globally recognized pharmaceutical firms and manufacturers of medical devices; specific partners not named publicly.

Beyond the preview

Go deeper on Aenorasis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aenorasis.

Explore the full profile